The Heifets Laboratory
Welcome to the Heifets Lab
Our research group is dedicated to understanding and improving on powerful, rapid-acting therapies for psychiatric disease, such as ketamine, MDMA and psilocybin. We bridge basic science and clinical trials, connecting neuroscience, psychiatry and anesthesiology in pursuit of highly effective, safe treatment strategies scalable to the millions of patients who need them.
Follow Us on Twitter
Really terrific work here. There is definitively the “moment of betrayal” when the participant is randomized to placebo. @TheBorisLab We need a new methodology for studying these consciousness altering drugs, especially in this environment of tremendous hope and hype.
🚨MAJOR NEW PAPER 🚨 just out in @JAMAPsych : Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions (https://tinyurl.com/yu2rbtaf).
I am very proud of this one, was a lot of work for me - both co-first and last author! Eternal
REMINDER: registration closing soon for our @Stanford class: *How to Communicate Science*
This class counts towards Stanford's Neuroscience PhD program requirements! 🎓
Sadly untrue but useful. The biggest bottleneck is choosing the right target. The rest is pretty straightforward
Just published: our RCT shows psilocybin (magic mushrooms) dramatically beats nicotine patch for quitting smoking using the same psychotherapy! A single psilocybin session showed 6x greater odds of staying quit. Biologically verified. In @JAMANetworkOpen Thread 🧵 #Psychedelics
New Kaye Lab preprint is out now! We used longitudinal dendritic spine imaging, synaptic proteomics, mini scope calcium imaging, and electrophysiology to study MDMA-induced plasticity and representational drift during fear extinction! 🔗⬇️
As efforts get underway to map the mouse, monkey and human connectomes, backed by private capital, I just want to shout out how important it will be for this information to be open and freely available to all. Companies can use it in their own ways, but the map doesn't belong to
🌲Stanford students! Our unique class “How to Communicate Science” is BACK for the Spring semester! Taught by @davideagleman and myself, with guest lecturers. Enrollment is open *now* at both the undergraduate (PSYC 108) and graduate (PSYC 208) levels!
Thank you @kwanalexc for an outstanding Stanford Psychiatry Grand Rounds "Making Synapses with Psychedelics" @StanfordBrain Tsai Neurosciences!!
Appreciate @TheBorisLab and Austen Casey for your kind hosting.
